US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

enVVeno Medical Corporation - Common Stock (NQ:NVNO)

8.100 +0.060 (+0.75%)
Delayed Quote Updated: 3:59 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about enVVeno Medical Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
Leading venous interventionalist Karen B. Garby, MD, DABVLM, RPhS, to present the enVVe ® System, a minimally invasive replacement venous valve currently being evaluated in a U.S. pivotal study An... 
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
New CEO-led video series provides investors with straight talk, just the facts, with no B.S. or corporate spin Real answers to what investors need to know about enVVeno and why they need to know it... 
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand
Access the video webcast here 
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
Via ACCESS Newswire
News headline image
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
Via ACCESS Newswire
News headline image
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
Via ACCESS Newswire
News headline image
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
Via ACCESS Newswire
News headline image
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Via ACCESS Newswire
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
enVVeno Medical Announces Reverse Stock Split
Via ACCESS Newswire
News headline image
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
Which stocks are moving on Friday? ↗
Intrigued by the market activity in the middle of the day on Friday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher ↗
 
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday. 
Via Chartmill
News headline image
Nasdaq Dips Over 300 Points; Applied Materials Posts Upbeat Q4 Earnings ↗
 
Via Benzinga
News headline image
Discover the top movers in Friday's pre-market session. ↗
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2 3 4 5 Next >